High-resolution transrectal ultrasound: Pilot study of a novel technique for imaging clinically localized prostate cancer

Christian Pavlovich, Toby C. Cornish, Jeffrey K. Mullins, Joel Fradin, Lynda Z. Mettee, Jason T. Connor, Adam C. Reese, Frederic B Askin, Rachael Luck, Jonathan Ira Epstein, Harry B. Burke

Research output: Contribution to journalArticle

Abstract

Objectives: To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer. Methods and materials: Twenty-five men with known prostate cancer scheduled for radical prostatectomy were preoperatively imaged with both LoTRUS (5. MHz) and HiTRUS (21. MHz). Dynamic cine loops and still images for each modality were saved and subjected to blinded review by a radiologist looking for hypoechoic foci≥5. mm in each sextant of the prostate. Following prostatectomy, areas of prostate cancer≥5. mm on pathologic review were anatomically correlated to LoTRUS and HiTRUS findings. The accuracy of LoTRUS and HiTRUS to visualize prostate cancer in each sextant of the prostate and to identify high-grade and locally advanced disease was assessed. The McNemar test was used to compare sensitivity and specificity and paired dichotomous outcomes between imaging modalities. Results: Among 69 sextants with pathologically identified cancerous foci at radical prostatecomy, HiTRUS visualized 45 and missed 24, whereas LoTRUS visualized 26 and missed 43. Compared with LoTRUS, HiTRUS demonstrated improved sensitivity (65.2% vs. 37.7%) and specificity (71.6% vs. 65.4%). HiTRUS's agreement with pathologic findings was twice as high as LoTRUS (P = 0.006). HiTRUS provided a nonsignificant increase in visualization of high-grade lesions (84% vs. 60%, P = 0.11). Conclusions: HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting.

Original languageEnglish (US)
JournalUrologic Oncology: Seminars and Original Investigations
Volume32
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Prostatic Neoplasms
Prostate
Prostatectomy
Clinical Trials
Biopsy
Sensitivity and Specificity

Keywords

  • Diagnosis
  • Prostate cancer
  • Radical prostatectomy
  • Sensitivity and specificity
  • Ultrasound

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

High-resolution transrectal ultrasound : Pilot study of a novel technique for imaging clinically localized prostate cancer. / Pavlovich, Christian; Cornish, Toby C.; Mullins, Jeffrey K.; Fradin, Joel; Mettee, Lynda Z.; Connor, Jason T.; Reese, Adam C.; Askin, Frederic B; Luck, Rachael; Epstein, Jonathan Ira; Burke, Harry B.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 1, 01.2014.

Research output: Contribution to journalArticle

@article{6a145072406b431dadf96e2344f4d11c,
title = "High-resolution transrectal ultrasound: Pilot study of a novel technique for imaging clinically localized prostate cancer",
abstract = "Objectives: To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer. Methods and materials: Twenty-five men with known prostate cancer scheduled for radical prostatectomy were preoperatively imaged with both LoTRUS (5. MHz) and HiTRUS (21. MHz). Dynamic cine loops and still images for each modality were saved and subjected to blinded review by a radiologist looking for hypoechoic foci≥5. mm in each sextant of the prostate. Following prostatectomy, areas of prostate cancer≥5. mm on pathologic review were anatomically correlated to LoTRUS and HiTRUS findings. The accuracy of LoTRUS and HiTRUS to visualize prostate cancer in each sextant of the prostate and to identify high-grade and locally advanced disease was assessed. The McNemar test was used to compare sensitivity and specificity and paired dichotomous outcomes between imaging modalities. Results: Among 69 sextants with pathologically identified cancerous foci at radical prostatecomy, HiTRUS visualized 45 and missed 24, whereas LoTRUS visualized 26 and missed 43. Compared with LoTRUS, HiTRUS demonstrated improved sensitivity (65.2{\%} vs. 37.7{\%}) and specificity (71.6{\%} vs. 65.4{\%}). HiTRUS's agreement with pathologic findings was twice as high as LoTRUS (P = 0.006). HiTRUS provided a nonsignificant increase in visualization of high-grade lesions (84{\%} vs. 60{\%}, P = 0.11). Conclusions: HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting.",
keywords = "Diagnosis, Prostate cancer, Radical prostatectomy, Sensitivity and specificity, Ultrasound",
author = "Christian Pavlovich and Cornish, {Toby C.} and Mullins, {Jeffrey K.} and Joel Fradin and Mettee, {Lynda Z.} and Connor, {Jason T.} and Reese, {Adam C.} and Askin, {Frederic B} and Rachael Luck and Epstein, {Jonathan Ira} and Burke, {Harry B.}",
year = "2014",
month = "1",
doi = "10.1016/j.urolonc.2013.01.006",
language = "English (US)",
volume = "32",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - High-resolution transrectal ultrasound

T2 - Pilot study of a novel technique for imaging clinically localized prostate cancer

AU - Pavlovich, Christian

AU - Cornish, Toby C.

AU - Mullins, Jeffrey K.

AU - Fradin, Joel

AU - Mettee, Lynda Z.

AU - Connor, Jason T.

AU - Reese, Adam C.

AU - Askin, Frederic B

AU - Luck, Rachael

AU - Epstein, Jonathan Ira

AU - Burke, Harry B.

PY - 2014/1

Y1 - 2014/1

N2 - Objectives: To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer. Methods and materials: Twenty-five men with known prostate cancer scheduled for radical prostatectomy were preoperatively imaged with both LoTRUS (5. MHz) and HiTRUS (21. MHz). Dynamic cine loops and still images for each modality were saved and subjected to blinded review by a radiologist looking for hypoechoic foci≥5. mm in each sextant of the prostate. Following prostatectomy, areas of prostate cancer≥5. mm on pathologic review were anatomically correlated to LoTRUS and HiTRUS findings. The accuracy of LoTRUS and HiTRUS to visualize prostate cancer in each sextant of the prostate and to identify high-grade and locally advanced disease was assessed. The McNemar test was used to compare sensitivity and specificity and paired dichotomous outcomes between imaging modalities. Results: Among 69 sextants with pathologically identified cancerous foci at radical prostatecomy, HiTRUS visualized 45 and missed 24, whereas LoTRUS visualized 26 and missed 43. Compared with LoTRUS, HiTRUS demonstrated improved sensitivity (65.2% vs. 37.7%) and specificity (71.6% vs. 65.4%). HiTRUS's agreement with pathologic findings was twice as high as LoTRUS (P = 0.006). HiTRUS provided a nonsignificant increase in visualization of high-grade lesions (84% vs. 60%, P = 0.11). Conclusions: HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting.

AB - Objectives: To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer. Methods and materials: Twenty-five men with known prostate cancer scheduled for radical prostatectomy were preoperatively imaged with both LoTRUS (5. MHz) and HiTRUS (21. MHz). Dynamic cine loops and still images for each modality were saved and subjected to blinded review by a radiologist looking for hypoechoic foci≥5. mm in each sextant of the prostate. Following prostatectomy, areas of prostate cancer≥5. mm on pathologic review were anatomically correlated to LoTRUS and HiTRUS findings. The accuracy of LoTRUS and HiTRUS to visualize prostate cancer in each sextant of the prostate and to identify high-grade and locally advanced disease was assessed. The McNemar test was used to compare sensitivity and specificity and paired dichotomous outcomes between imaging modalities. Results: Among 69 sextants with pathologically identified cancerous foci at radical prostatecomy, HiTRUS visualized 45 and missed 24, whereas LoTRUS visualized 26 and missed 43. Compared with LoTRUS, HiTRUS demonstrated improved sensitivity (65.2% vs. 37.7%) and specificity (71.6% vs. 65.4%). HiTRUS's agreement with pathologic findings was twice as high as LoTRUS (P = 0.006). HiTRUS provided a nonsignificant increase in visualization of high-grade lesions (84% vs. 60%, P = 0.11). Conclusions: HiTRUS appears promising for prostate cancer imaging. Our initial experience suggests superiority to LoTRUS for the visualization of cancerous foci, and supports proceeding with a clinical trial in the biopsy setting.

KW - Diagnosis

KW - Prostate cancer

KW - Radical prostatectomy

KW - Sensitivity and specificity

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84890804539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890804539&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2013.01.006

DO - 10.1016/j.urolonc.2013.01.006

M3 - Article

C2 - 23558161

AN - SCOPUS:84890804539

VL - 32

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 1

ER -